Fragment-type 4-azolylcoumarin derivatives with anticancer properties

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Coumarin derivatives are explored for diverse biological activities.
• The introduction of azole substituents can modulate pharmacological properties.

Purpose of the Study:

• To synthesize and evaluate novel coumarin derivatives with azole substituents at the C-4 position for anticancer properties.
• To assess the efficacy of these compounds against various human cancer cell lines.

Main Methods:

• Synthesis of 4-azole coumarin derivatives.
• Anticancer activity evaluation using the MTT assay on HeLa, K-562, MDA-MB-53, and MCF-7 cell lines.
• Comparison with cisplatin as a standard treatment.
• Cell cycle analysis and zebrafish embryo toxicity assessment.

Main Results:

• K-562 cells showed the highest sensitivity to compounds 3c, 4a, and 4c, with IC50 values comparable to cisplatin.
• Compound 4c also demonstrated potent activity against MCF-7 cells.
• Mechanism of action may involve cell cycle interference.
• No significant toxicity was observed in zebrafish embryos.

Conclusions:

• 4-Azole coumarins represent a promising class of anticancer agents.
• Further optimization is warranted to enhance activity and drug-like properties.
• Fragment-like characteristics (MW <300, clogP <3) suggest potential for favorable pharmacokinetic profiles.